KEYZELL

LOGO KEYZELL

Contact information

Keyzell Holding, S.L.
José del Corral - CEO
Avenida de la Aeronáutica, 10, planta 7, puerta 3
Sevilla, C.P. 41020
Sevilla
+34 620 473 830
Areas of activities
  • Diagnostic imaging
  • Screening
  • Oncology
  • Bioinformatics

KeyZell is a bio-pharmaceutical company established in 2020 with subsidiaries in the United Kingdom, Australia, Thailand, and Mexico. Our primary goal is to bring a frontline molecule to market for cancer treatment, alongside two artificial intelligence-based platforms for cancer combat. 

Products and services
  • LZ 167 (peptide)
  • OPS (Oncology Precision System AI)
  • ODS (Oncology Diagnosis System AI)
Areas of interest for future collaborations

Regenerative Therapies, and Stem Cells.